Mary Wilson
Well-known member
Published: 18 November 2021
DOI https://doi.org/10.1038/s41582-021-00593-7
Abdul Mannan Baig
Refers to Misra, S. et al. Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis. Neurologyhttps://doi.org/10.1212/WNL.0000000000012930 (2021)
Valencia Sanchez, C. et al. Autoimmune encephalitis post-SARS-CoV-2 infection: case frequency, findings, and outcomes. Neurologyhttps://doi.org/10.1212/WNL.0000000000012931 (2021).
The ongoing global COVID-19 pandemic, caused by the SARS-CoV-2 virus, has affected individuals from all walks of life, imposing a colossal burden on clinicians and overwhelming the health-care apparatus in many countries. Despite multiple reports of neurological deficits in patients with COVID-19 from across the world, the precise incidence of these manifestations has remained unknown, and two new studies have attempted to address this issue.
In a systematic review and meta-analysis[SUP]1[/SUP], Shubham Misra and colleagues detailed the occurrence of syndromic expression of neurological involvement in COVID-19 and probed the association of neurological indices with disease severity and mortality in patients with COVID-19. By analysing data from 55 countries, they identified 41 neurological manifestations that can occur in conjunction with COVID-19. Up to one-third of individuals with COVID-19 were estimated to exhibit at least one of these manifestations.
Differences in the prevalence of the various neurological symptoms were observed between older (aged 60 years or more) and young (aged less than 18 years) subpopulations. ...
https://www.nature.com/articles/s415...-7?s=09#citeas
DOI https://doi.org/10.1038/s41582-021-00593-7
Abdul Mannan Baig
Refers to Misra, S. et al. Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis. Neurologyhttps://doi.org/10.1212/WNL.0000000000012930 (2021)
Valencia Sanchez, C. et al. Autoimmune encephalitis post-SARS-CoV-2 infection: case frequency, findings, and outcomes. Neurologyhttps://doi.org/10.1212/WNL.0000000000012931 (2021).
The ongoing global COVID-19 pandemic, caused by the SARS-CoV-2 virus, has affected individuals from all walks of life, imposing a colossal burden on clinicians and overwhelming the health-care apparatus in many countries. Despite multiple reports of neurological deficits in patients with COVID-19 from across the world, the precise incidence of these manifestations has remained unknown, and two new studies have attempted to address this issue.
In a systematic review and meta-analysis[SUP]1[/SUP], Shubham Misra and colleagues detailed the occurrence of syndromic expression of neurological involvement in COVID-19 and probed the association of neurological indices with disease severity and mortality in patients with COVID-19. By analysing data from 55 countries, they identified 41 neurological manifestations that can occur in conjunction with COVID-19. Up to one-third of individuals with COVID-19 were estimated to exhibit at least one of these manifestations.
Differences in the prevalence of the various neurological symptoms were observed between older (aged 60 years or more) and young (aged less than 18 years) subpopulations. ...
https://www.nature.com/articles/s415...-7?s=09#citeas